A Prospective Evaluation Of Galectin 9 And Galectin 3 As Novel Therapeutic Targets For The Treatment Of IBD

Project Details

Short titleA Prospective Evaluation Of Galectin 9 And Galectin 3 As Novel Therapeutic Targets For The Treatment Of IBD
StatusActive
Effective start/end date1/03/2031/03/23

Funding

  • F HOFFMANN-LA ROCHE AG